DE60009472D1 - Schnell dispergierende darreichungsformen, die fischgelatine enthalten - Google Patents

Schnell dispergierende darreichungsformen, die fischgelatine enthalten

Info

Publication number
DE60009472D1
DE60009472D1 DE60009472T DE60009472T DE60009472D1 DE 60009472 D1 DE60009472 D1 DE 60009472D1 DE 60009472 T DE60009472 T DE 60009472T DE 60009472 T DE60009472 T DE 60009472T DE 60009472 D1 DE60009472 D1 DE 60009472D1
Authority
DE
Germany
Prior art keywords
composition
pharmaceutical forms
forms containing
active ingredient
fast dispersing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60009472T
Other languages
English (en)
Other versions
DE60009472T2 (de
Inventor
Owen Murray
Michael Hall
Richard Green
Patrick Kearney
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RP Scherer Technologies LLC
Original Assignee
Catalent Pharma Solutions Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Catalent Pharma Solutions Inc filed Critical Catalent Pharma Solutions Inc
Publication of DE60009472D1 publication Critical patent/DE60009472D1/de
Application granted granted Critical
Publication of DE60009472T2 publication Critical patent/DE60009472T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2063—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE60009472T 1999-04-08 2000-04-07 Schnell dispergierende darreichungsformen, die fischgelatine enthalten Expired - Lifetime DE60009472T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9908014.5A GB9908014D0 (en) 1999-04-08 1999-04-08 Pharmaceutical compositions
GB9908014 1999-04-08
PCT/US2000/009278 WO2000061117A1 (en) 1999-04-08 2000-04-07 Fast-dispersing dosage forms containing fish gelatin

Publications (2)

Publication Number Publication Date
DE60009472D1 true DE60009472D1 (de) 2004-05-06
DE60009472T2 DE60009472T2 (de) 2004-12-23

Family

ID=10851154

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60009472T Expired - Lifetime DE60009472T2 (de) 1999-04-08 2000-04-07 Schnell dispergierende darreichungsformen, die fischgelatine enthalten

Country Status (28)

Country Link
US (2) US6709669B1 (de)
EP (1) EP1165053B1 (de)
JP (1) JP4838939B2 (de)
KR (1) KR100767076B1 (de)
CN (1) CN1224381C (de)
AT (1) ATE262890T1 (de)
AU (1) AU761439B2 (de)
BR (1) BR0009609A (de)
CA (1) CA2369715C (de)
CZ (1) CZ295324B6 (de)
DE (1) DE60009472T2 (de)
DK (1) DK1165053T3 (de)
ES (1) ES2215645T3 (de)
GB (1) GB9908014D0 (de)
HK (1) HK1039066B (de)
HU (1) HU229892B1 (de)
IL (2) IL145783A0 (de)
IS (1) IS2403B (de)
MX (1) MXPA01010094A (de)
NO (1) NO330196B1 (de)
NZ (1) NZ515230A (de)
PL (1) PL196572B1 (de)
PT (1) PT1165053E (de)
RO (1) RO122011B1 (de)
RU (1) RU2242969C2 (de)
TR (1) TR200102881T2 (de)
WO (1) WO2000061117A1 (de)
ZA (1) ZA200109089B (de)

Families Citing this family (87)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040023948A1 (en) * 1997-03-24 2004-02-05 Green Richard David Fast-dispersing dosage form containing 5-HT1 agonists
GB9908014D0 (en) * 1999-04-08 1999-06-02 Scherer Corp R P Pharmaceutical compositions
GB9910505D0 (en) * 1999-05-06 1999-07-07 Electrosols Ltd A method and apparatus for manufacturing consumable tablets
EP1238675A1 (de) * 2001-03-06 2002-09-11 Fuji Photo Film B.V. Rekombinante gelatineartige Proteine zur Verwendung als Plasmaexpander
ITRM20010380A1 (it) * 2001-07-02 2003-01-02 Bioprogress Spa Composizione comprendente gelatina di pesce parzialmente idrolizzata e loro uso.
ATE303075T1 (de) * 2001-07-02 2005-09-15 Bioprogress Spa Teilhydrolysierte fischgelatine enthaltende zubereitungen und deren verwendung
KR100425226B1 (ko) * 2001-07-03 2004-03-30 주식회사 팜트리 아세클로페낙을 함유하는 경제적인 경구용 제제의 조성 및제법
GB0125061D0 (en) * 2001-10-18 2001-12-12 Norton Healthcare Ltd Pharmaceutical composition
GB0210397D0 (en) 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
PT1501534E (pt) * 2002-05-07 2006-09-29 Ferring Bv Formulacoes farmaceuticas
GB0226076D0 (en) * 2002-11-08 2002-12-18 Rp Scherer Technologies Inc Improved formulations containing substituted imidazole derivatives
MXPA05005528A (es) * 2002-11-26 2006-04-05 Alk Abello As Producto farmaceutico de alergeno.
UA93479C2 (en) * 2002-11-26 2011-02-25 Альк-Абелло A/C Allergen dosage form
US20040156894A1 (en) * 2003-02-07 2004-08-12 Grother Leon Paul Use of edible acids in fast-dispersing pharmaceutical solid dosage forms
AU2004216559B2 (en) 2003-02-28 2010-05-27 Alk-Abello A/S Dosage form having a saccharide matrix
US8012505B2 (en) 2003-02-28 2011-09-06 Alk-Abello A/S Dosage form having a saccharide matrix
EP1689419A4 (de) 2003-11-10 2009-01-14 Reprise Biopharmaceutics Llc Pharmazeutische zusammensetzungen mit niedrigen dosen von desmopressin
DE20321887U1 (de) 2003-11-10 2012-01-20 Allergan, Inc. Arzneimittel umfassend niedrige Dosierungen von Desmopressin
DK1530967T3 (da) 2003-11-13 2006-07-03 Ferring Bv Blisterpakning og dertil hörende fast dosisform
US9241902B2 (en) 2003-12-17 2016-01-26 R.P. Scherer Technologies, Llc Chewable soft capsules containing ungelatinized starch
US7972621B2 (en) * 2004-06-03 2011-07-05 R.P. Scherer Technologies, Llc Process for formulating fast dispersing dosage forms comprising at least one fish gelatin selected on the basis of molecular weight
EP1817009A2 (de) * 2004-11-24 2007-08-15 Spi Pharma, Inc. Oral zerfallende zusammensetzungen
MX2007007885A (es) * 2004-12-23 2007-10-04 Johnson & Johnson Composiciones farmaceuticas oralmente desintegrables con agentes de indicacion sensorial.
US20060210590A1 (en) 2005-02-03 2006-09-21 Alk-Abello A/S Minor allergen control to increase safety of immunotherapy
CA2608716A1 (en) * 2005-05-19 2006-11-23 Kilda Biolink As Gelatin-containing topical composition
GB0510286D0 (en) * 2005-05-19 2005-06-29 Kilda Biolink As Composition
TW200816985A (en) * 2006-06-05 2008-04-16 Verus Pharmaceuticals Inc Methods for buccal, lingual or sublingual dosing regimens of epinephrine for the treatment of allergic emergencies
US20070293582A1 (en) * 2006-06-05 2007-12-20 Malcolm Hill Epinephrine dosing regimens comprising buccal, lingual or sublingual and injectable dosage forms
US20080014228A1 (en) * 2006-07-14 2008-01-17 Olivia Darmuzey Solid form
TWI343262B (en) * 2006-09-26 2011-06-11 Schering Corp Rapidly disintegrating lyophilized oral formulations of a thrombin receptor antagonist
US20090214442A1 (en) * 2006-12-01 2009-08-27 Cephalon, Inc. Oral Transmucosal Nicotine Dosage Form
JP2010511611A (ja) * 2006-12-01 2010-04-15 シマ ラブス インク． 口腔経粘膜ニコチン剤形
US20080311162A1 (en) * 2007-05-16 2008-12-18 Olivia Darmuzey Solid form
CA2689434C (en) * 2007-06-04 2017-09-26 Shear/Kershman Laboratories, Inc. Tamper resistant lipid-based oral dosage form for opioid agonists
US20090004231A1 (en) * 2007-06-30 2009-01-01 Popp Shane M Pharmaceutical dosage forms fabricated with nanomaterials for quality monitoring
KR100905027B1 (ko) * 2007-10-03 2009-06-30 (주)씨엘팜 식용 필름
GB2453770A (en) 2007-10-19 2009-04-22 Reckitt Benckiser Healthcare Oral composition comprising a cooling agent
MY173867A (en) * 2008-02-28 2020-02-25 Scherer Technologies Llc R P Process to minimize polymorphism
US11963995B2 (en) 2008-05-21 2024-04-23 Ferring B.V. Methods comprising desmopressin
NO2296686T3 (de) 2008-05-21 2014-07-12
US20100286045A1 (en) 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin
US8420700B1 (en) * 2008-06-04 2013-04-16 James M. Bausch Tamper resistant lipid-based oral dosage form for sympathomimetic amines
CA2729972C (en) * 2008-08-05 2018-11-20 Wyeth Llc Lyophilization above collapse
JP2010143860A (ja) * 2008-12-19 2010-07-01 Chisso Corp タンパク質の安定化剤
TWI471127B (zh) 2009-04-29 2015-02-01 Intervet Int Bv 供人類使用之口服崩解錠劑的製備方法、所製得之口服崩解錠劑、以及含有該口服崩解錠劑的包裝物
US9539302B2 (en) 2009-06-18 2017-01-10 Allergan, Inc. Safe desmopressin administration
US8545879B2 (en) * 2009-08-31 2013-10-01 Wilmington Pharmaceuticals, Llc Fast disintegrating compositions of meloxicam
US9775819B2 (en) * 2009-09-16 2017-10-03 R.P. Scherer Technologies, Llc Oral solid dosage form containing nanoparticles and process of formulating the same using fish gelatin
CN102933207B (zh) 2009-10-30 2018-02-02 Ix生物医药有限公司 快速溶解固体剂型
US10548839B2 (en) 2010-03-16 2020-02-04 Wei Tian Process of manufacturing a lyophilized fast dissolving, multi-phasic dosage form
JO3112B1 (ar) 2010-03-29 2017-09-20 Ferring Bv تركيبة دوائية سريعة التحلل
KR101790188B1 (ko) 2010-03-29 2017-10-25 훼링 비.브이. 속용성 약학 조성물
DK2624815T3 (en) * 2010-10-08 2016-11-07 Scherer Technologies Llc R P Oral vaccine in rapidly dissolving dosage form using starch
JP2012121850A (ja) * 2010-12-09 2012-06-28 Otsuka Pharmaceut Co Ltd アリピプラゾールの経口速溶性組成物
WO2012106058A2 (en) 2011-01-31 2012-08-09 New Market Pharmaceuticals Animal treatments
JP2011116764A (ja) * 2011-02-08 2011-06-16 Fine Seymour H 低用量デスモプレシンを含有する医薬組成物
JP6174585B2 (ja) 2011-09-16 2017-08-02 フェリング ベスローテン フェンノートシャップ 速溶性医薬組成物
WO2013165468A1 (en) 2012-05-02 2013-11-07 New Market Pharmaceuticals Pharmaceutical compositions for direct systemic introduction
TW201422254A (zh) 2012-11-21 2014-06-16 Ferring Bv 用於速釋及延釋的組成物
JP2015172084A (ja) * 2015-07-06 2015-10-01 大塚製薬株式会社 アリピプラゾールの経口速溶性組成物
CN107397208B (zh) * 2016-07-20 2021-05-07 吴登成 以鱼鳔胶为主成分的功能食品及其用途
CA3040422A1 (en) 2016-10-13 2018-04-19 Catalent U.K. Swindon Zydis Limited Lyophilized pharmaceutical compositions for vaginal delivery
WO2018078548A1 (en) 2016-10-25 2018-05-03 Catalent U.K. Swindon Zydis Limited Compositions of different densities for fast disintegrating multi-layer tablet
MX2019007923A (es) 2016-12-31 2019-09-10 Bioxcel Therapeutics Inc Uso de dexmedetomidina sublingual para el tratamiento de la agitacion.
WO2018130603A1 (en) 2017-01-11 2018-07-19 Ferring B.V. A fast disintegrating pharmaceutical composition
DE102017104472A1 (de) 2017-03-03 2018-09-06 Nordmark Arzneimittel Gmbh & Co. Kg Schmelztablette enthaltend Burlulipase und daraus hergestellte pharmazeutische Zusammensetzung
US10517834B2 (en) * 2017-05-16 2019-12-31 Owen Murray Fast dissolving tablet formulations and methods of making thereof
WO2018237000A1 (en) * 2017-06-20 2018-12-27 Seattle Gummy Company PECTIN-BASED GEL COMPOSITION AND METHODS OF MAKING AND USING THE SAME
WO2019171173A1 (en) 2018-03-08 2019-09-12 Catalent U.K. Swindon Zydis Limited Process to reduce endotoxin in gelatin
US20210000814A1 (en) * 2018-03-25 2021-01-07 Biohaven Pharmaceutical Holding Company Ltd. Rimegepant for cgrp related disorders
JP2021525714A (ja) * 2018-05-27 2021-09-27 バイオヘイブン・ファーマシューティカル・ホールディング・カンパニー・リミテッドＢｉｏｈａｖｅｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌ Ｈｏｌｄｉｎｇ Ｃｏｍｐａｎｙ Ｌｔｄ． 疾患の処置のためのリルゾール口腔内崩壊錠の使用
CN114983979A (zh) 2018-06-27 2022-09-02 比奥克斯塞尔医疗股份有限公司 含右美托咪定的膜制剂及其制造方法
MX2021001563A (es) * 2018-08-16 2021-06-15 Biohaven Therapeutics Ltd Uso de tabletas de desintegracion oral de riluzol para tratar enfermedades.
CN113316470A (zh) * 2019-01-20 2021-08-27 拜尔哈文制药股份有限公司 用于治疗偏头痛突破的cgrp拮抗剂
CA3129395A1 (en) 2019-02-22 2020-08-27 Catalent U.K. Swindon Zydis Limited Minimizing agglomeration, aeration, and preserving the coating of pharmaceutical compositions comprising ibuprofen
AU2020225448A1 (en) 2019-02-22 2021-10-14 Catalent U.K. Swindon Zydis Limited Minimizing agglomeration of drug particle coating material during storage to stabilize disintegration times of pharmaceutical products
AU2020224375A1 (en) 2019-02-22 2021-10-14 Catalent U.K. Swindon Zydis Limited Minimizing aeration of suspensions during in-line mixing
CA3129404A1 (en) 2019-02-22 2020-08-27 Catalent U.K. Swindon Zydis Limited Preserving functionally-coated api particles produced by solventless mixing processes in aqueous suspension
CN114375191A (zh) 2019-07-19 2022-04-19 比奥克斯塞尔医疗股份有限公司 非镇静的右美托咪定治疗方案
WO2021132741A1 (ko) * 2019-12-23 2021-07-01 주식회사 피엘마이크로메드 색전 시술 입자 및 이의 제조방법
AR123109A1 (es) 2020-07-31 2022-10-26 Catalent Uk Swindon Zydis Ltd Composiciones farmacéuticas que comprenden ifa
JP2023543710A (ja) 2020-09-17 2023-10-18 キャタレント・ユーケー・スウィンドン・ザイディス・リミテッド 流動特性を改善するための、高分子量魚ゼラチンに基づく投薬製剤を伴う、界面活性剤の使用
WO2022103638A1 (en) * 2020-11-16 2022-05-19 Orcosa Inc. Cannabinoids in the treatment of autism spectrum disorder
US11672761B2 (en) * 2020-11-16 2023-06-13 Orcosa Inc. Rapidly infusing platform and compositions for therapeutic treatment in humans
WO2022179635A1 (zh) * 2021-02-27 2022-09-01 北京兴源联合医药科技有限公司 一种β-烟酰胺单核苷酸冻干口服制剂
BR112023025552A2 (pt) 2021-06-11 2024-02-27 Orphai Therapeutics Inc Composições estabilizadas de apilimod e usos das mesmas
IL310591A (en) * 2021-08-19 2024-04-01 Mind Medicine Inc Lyophilized orally disintegrating tablet formulations of d-lysergic acid diethylamide for therapeutic applications

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2246013A1 (de) 1972-09-20 1974-03-28 Boehringer Mannheim Gmbh Verfahren zur herstellung von poroesen tabletten
DE2556561C2 (de) 1975-12-16 1983-04-14 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur Herstellung von porösen Tabletten
IE45770B1 (en) * 1976-10-06 1982-11-17 Wyeth John & Brother Ltd Pharmaceutical dosage forms
GB1548022A (en) * 1976-10-06 1979-07-04 Wyeth John & Brother Ltd Pharmaceutial dosage forms
US4139497A (en) * 1977-04-04 1979-02-13 The Dow Chemical Company Dehydrogenation catalyst tablet and method for making same
US4762719A (en) * 1986-08-07 1988-08-09 Mark Forester Powder filled cough product
US5035896A (en) * 1988-06-15 1991-07-30 Warner-Lambert Company Water insoluble drugs coated by coacervated fish gelatin
MC2034A1 (fr) 1988-06-23 1990-05-30 Hoffmann La Roche Preparations
IL87344A (en) 1988-08-04 1992-03-29 Univ Bar Ilan Process for the production of gelatin from fish skins
US4935243A (en) 1988-12-19 1990-06-19 Pharmacaps, Inc. Chewable, edible soft gelatin capsule
US4946684A (en) * 1989-06-20 1990-08-07 American Home Products Corporation Fast dissolving dosage forms
US5079018A (en) 1989-08-14 1992-01-07 Neophore Technologies, Inc. Freeze dry composition and method for oral administration of drugs, biologicals, nutrients and foodstuffs
EP0737473A1 (de) 1989-10-02 1996-10-16 Cima Labs, Inc. Brausedosisform
JPH06500632A (ja) 1990-08-10 1994-01-20 アナリティカル・コントロール・システムズ・インコーポレーテッド 改良された診断および治療組成物
FR2679451B1 (fr) 1991-07-22 1994-09-09 Prographarm Laboratoires Comprime multiparticulaire a delitement rapide.
CA2120701A1 (en) * 1991-10-11 1993-04-15 Sharon M. Devereaux Unit-of-use reagent composition for specific binding assays
AU666509B2 (en) 1991-12-24 1996-02-15 Yamanouchi Pharmaceutical Co., Ltd. Intrabuccally disintegrating preparation and production thereof
ATE147261T1 (de) 1992-01-13 1997-01-15 Pfizer Verfahren zur herstellung von tabletten mit hoher festigkeit
US5298261A (en) 1992-04-20 1994-03-29 Oregon Freeze Dry, Inc. Rapidly distintegrating tablet
FR2702968B1 (fr) 1993-03-23 1995-06-23 Lafon Labor Procédé de préparation de particules renfermant un ingrédient actif par extrusion et lyophilisation .
EP0804170B1 (de) * 1993-07-09 2001-11-14 R.P. Scherer Corporation Verfahren zur herstellung von gefriergetrockneten arzneistoffdosierungsformen
US5382437A (en) 1993-10-25 1995-01-17 Hunter Research Corporation Frozen liquified gas composition and method for oral administration of drugs, biologicals, nutrients and foodstuffs
US5595761A (en) * 1994-01-27 1997-01-21 The Board Of Regents Of The University Of Oklahoma Particulate support matrix for making a rapidly dissolving tablet
US5484888A (en) 1994-03-08 1996-01-16 Holzer; David Gelatin production
US5603952A (en) 1994-12-30 1997-02-18 Tastemaker Method of encapsulating food or flavor particles using warm water fish gelatin, and capsules produced therefrom
GB9517062D0 (en) * 1995-08-18 1995-10-25 Scherer Ltd R P Pharmaceutical compositions
AU2636797A (en) * 1996-04-16 1997-11-07 Novartis Consumer Health S.A. Fast disintegrating oral dosage form
US5879796A (en) * 1996-09-05 1999-03-09 E. I. Du Pont De Nemours And Company Organic/inorganic particulates
US6071963A (en) * 1996-11-06 2000-06-06 Roche Vitamins Inc. Water dispersible compositions
WO1998043640A1 (en) * 1997-04-03 1998-10-08 Bridge Pharma, Inc. Benzocycloheptathiophene compounds
FR2766089B1 (fr) * 1997-07-21 2000-06-02 Prographarm Lab Comprime multiparticulaire perfectionne a delitement rapide
US6077540A (en) * 1997-08-08 2000-06-20 Bayer Corporation Gelatin spray coating
US6020003A (en) * 1998-02-23 2000-02-01 Basf Corporation Method of making spray-dried powders with high edible-oil loadings based on non-hydrolyzed gelatin
GB9908014D0 (en) * 1999-04-08 1999-06-02 Scherer Corp R P Pharmaceutical compositions
US6284270B1 (en) * 1999-08-04 2001-09-04 Drugtech Corporation Means for creating a mass having structural integrity
US7972621B2 (en) * 2004-06-03 2011-07-05 R.P. Scherer Technologies, Llc Process for formulating fast dispersing dosage forms comprising at least one fish gelatin selected on the basis of molecular weight

Also Published As

Publication number Publication date
US6709669B1 (en) 2004-03-23
EP1165053A4 (de) 2002-06-12
AU4333100A (en) 2000-11-14
IL145783A (en) 2006-10-31
CN1224381C (zh) 2005-10-26
TR200102881T2 (tr) 2002-05-21
EP1165053B1 (de) 2004-03-31
US20040076666A1 (en) 2004-04-22
ES2215645T3 (es) 2004-10-16
DE60009472T2 (de) 2004-12-23
JP4838939B2 (ja) 2011-12-14
HK1039066A1 (en) 2002-04-12
NO20014859D0 (no) 2001-10-05
CZ20013588A3 (cs) 2002-06-12
WO2000061117A1 (en) 2000-10-19
RU2242969C2 (ru) 2004-12-27
IS6102A (is) 2001-10-04
NO20014859L (no) 2001-11-19
KR100767076B1 (ko) 2007-10-17
IL145783A0 (en) 2002-07-25
PL354958A1 (en) 2004-03-22
KR20020000160A (ko) 2002-01-04
EP1165053A1 (de) 2002-01-02
ZA200109089B (en) 2003-04-30
PT1165053E (pt) 2004-06-30
HUP0201877A2 (hu) 2002-11-28
JP2003524622A (ja) 2003-08-19
CN1350450A (zh) 2002-05-22
NO330196B1 (no) 2011-03-07
NZ515230A (en) 2004-01-30
ATE262890T1 (de) 2004-04-15
IS2403B (is) 2008-09-15
BR0009609A (pt) 2002-02-13
HK1039066B (zh) 2004-08-13
CA2369715C (en) 2006-03-21
AU761439B2 (en) 2003-06-05
GB9908014D0 (en) 1999-06-02
HU229892B1 (en) 2014-11-28
DK1165053T3 (da) 2004-06-01
CA2369715A1 (en) 2000-10-19
US9192580B2 (en) 2015-11-24
HUP0201877A3 (en) 2004-05-28
MXPA01010094A (es) 2002-05-06
CZ295324B6 (cs) 2005-07-13
PL196572B1 (pl) 2008-01-31
RO122011B1 (ro) 2008-11-28

Similar Documents

Publication Publication Date Title
DE60009472D1 (de) Schnell dispergierende darreichungsformen, die fischgelatine enthalten
ATE340563T1 (de) DOSIERUNGSFORM DES TYPS ßHÜLLE UND KERNß MIT EINER WIRKSTOFFFREISETZUNG, DIE SICH DER NULLTEN ORDNUNG ANNÄHERT
HUP0104031A2 (hu) Új eljárás mikrokapszulázott készítmények előállítására
ATE211907T1 (de) Osmotisches arzneimittelfreisetzungssystem
IT1246383B (it) Metodo per il mascheramento del sapore di farmaci
DK0696921T3 (da) Veterinært præparat indeholdende en protonpumpeinhibitor
RU2000100756A (ru) Способы и составы для модулирования сексуальной реакции человека
EE9900288A (et) Peroraalselt manustatava farmatseutilise kompositsiooni kasutamine meeste erektiilse talitlushäire raviks ettenähtud ravimi valmistamiseks
UA42061C2 (uk) Фармацевтична композиція для перорального введення, що містить інгібітори протонного насоса
ATE198152T1 (de) Oral anzuwendende arzneizubereitung mit verzögerter wirkstoffabgabe
DE69940674D1 (de) Orale verabreichung von adenosin analogen
HUP9801152A2 (hu) Nem-szteroid analgetikumok átlátszó, gyors hatóanyagkibocsátású készítményei
ATE260645T1 (de) Agitationsunabhängige pharmazeutische multiple- unit-retardzubereitungen und verfahren zu ihrer herstellung
SE9700885D0 (sv) New pharmaceutical formulation
DK0615442T3 (da) Solreguleret termokolloidmatrix på gelatinebasis til perorale former med retarderet frigivelse.
RS50298B (sr) Direktno kompresibilna matrica za kontrolisano oslobađanje pojedinačnih dnevnih doza klaritromicina
SG145717A1 (en) Composition for releasing a weak base for an extended period of time
AP1736A (en) Oral dosage form for controlled drug release.
EE03954B1 (et) Toimeaine pärsitud vabanemisega karbamasepiini ravimvormi valmistamise meetod
HUP9900313A1 (hu) Antiösztrogének alkalmazása hím nemzőképesség szabályozására
ES2004693A6 (es) Un procedimiento para la preparacion de una composicion farmaceutica solida administrable por via oral, que contiene vinburnina como principio activo.
RU97109989A (ru) Способ лечения вагинозов и вагинитов у беременных
AR224929Q (es) Procedimiento para la preparacion de formas medicamentosas administrable por via oral,de liberacion uniforme e independiente del ph de una sustancia activa soluble en agua
RU98105696A (ru) Средство для лечения и профилактики болезней полости рта

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: R.P. SCHERER TECHNOLOGIES, INC., LAS VEGAS, NEV.,

8364 No opposition during term of opposition